Home / Alternatives to NephRef Apps Like NephRef for iPhone and iPad
by Media Foundations LLC ★ 5.0 1 ratings Medical Free Data updated 2026-09-20
Ranked alternatives Showing 881–900 of 1,000 ranked alternatives.
CONSTEL PTY. LIMITED
★ 0.0 0 ratings Medical Free Data updated 2026-09-06
Skyscape Medpresso Inc
★ 0.0 0 ratings Medical Free Data updated 2026-09-06
Rainbow Health LLC
★ 0.0 0 ratings Health & Fitness Free Data updated 2026-09-06
Savannah Informatics
★ 0.0 0 ratings Health & Fitness Free Data updated 2026-09-06
Myopoint AG
★ 0.0 0 ratings Medical Free Data updated 2026-09-22
Children's Research Institute
★ 0.0 0 ratings Medical Free Data updated 2026-09-21
HJ SARL
★ 0.0 0 ratings Medical Free Data updated 2026-11-11
Medstori LLC
★ 0.0 0 ratings Medical Free Data updated 2026-09-06
Matthias Unterhuber
Predict treatment response with XGBoost models
Predict individual response to spironolactone therapy in HFpEF patients using a gradient-boosting model. Input patient data to estimate treatment effect. Provides research-based predictions for clinical validation.
★ 0.0 0 ratings Medical Free Data updated 2026-09-06
BODY BLU
★ 0.0 0 ratings Medical Free Data updated 2026-09-06
COMERCIAL ERNESFANY CORP
★ 0.0 0 ratings Medical Free Data updated 2026-09-06
iCare Digital Health Technology LLC
★ 0.0 0 ratings Medical Free Data updated 2026-09-06
CODINGA
★ 0.0 0 ratings Health & Fitness Free Data updated 2026-09-06
Tennessee Cardiology LLC
★ 0.0 0 ratings Health & Fitness $24.99 Data updated 2026-11-16
David Vaccaro
★ 0.0 0 ratings Medical $2.99 Data updated 2026-09-06
Meccasoft, LLC
★ 0.0 0 ratings Medical Free Data updated 2026-09-06
Expanded Apps, Inc.
★ 0.0 0 ratings Medical Free Data updated 2026-09-13
Skyscape Medpresso Inc
★ 0.0 0 ratings Medical Free Data updated 2026-09-06
ITDCS Ltd
★ 0.0 0 ratings Medical Free Data updated 2026-09-06
The Carter Center, Inc
★ 0.0 0 ratings Medical Free Data updated 2026-09-06
How we rank alternatives Apps are ranked by functional similarity, category fit, rating confidence, and popularity.
Previous Next